Accretion Pharmaceuticals Ltd

Mon 21/09/2026,9:19:20 | NSE : ACCPL

₹210.000.00 (0.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 0.00

Previous Close

₹ 210.00

Volume

0

Mkt Cap ( ₹ Cr)

₹ 233.44

High

₹ 0.00

Low

₹ 0.00

52 Week High

₹ 219.00

52 Week Low

₹ 53.80

Book Value Per Share

₹ 49.22

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Accretion Pharmaceuticals Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

60%

Sell Order Quantity

40%

Bid Price

Qty

203.15

1200

203.00

1200

200.00

1200

0.00

0

0.00

0

Bid Total

3600

Bid Price

Qty

220.45

1200

220.00

1200

0.00

0

0.00

0

0.00

0

Bid Total

2400

Option Chain

Analyzes market sentiment, predicts Accretion Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Accretion Pharma. - Copy of Newspaper Publication

    10 Sep 2026, 2:50PM Accretion Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Accretion Pharma. - Shareholders meeting

    9 Sep 2026, 8:31PM Accretion Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot
  • Accretion Pharma. - General Updates

    1 Sep 2026, 1:46PM Accretion Pharmaceuticals Limited has informed the Exchange about General Updates
  • Accretion Pharma. - Amendment to AOA/MOA

    1 Sep 2026, 1:45PM Accretion Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Accretion Pharma. - Shareholders meeting

    27 Aug 2026, 7:54PM Accretion Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026
  • Accretion Pharma. - Shareholders meeting

    27 Aug 2026, 4:05PM Accretion Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2026
  • Accretion Pharma. - General Updates

    5 Aug 2026, 4:38PM Accretion Pharmaceuticals Limited has informed the Exchange about General Updates - Letter regarding web Link of Annual Report to Shareholders
  • Accretion Pharma. - Copy of Newspaper Publication

    4 Aug 2026, 12:58PM Accretion Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Accretion Pharma. - Shareholders meeting

    3 Aug 2026, 7:39PM Accretion Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 27, 2026
  • Accretion Pharma. - Copy of Newspaper Publication

    1 Aug 2026, 5:27PM Accretion Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Accretion Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    16 Jul 2026, 9:00PM As of June 2026, 73.52% is owned by Indian Promoters and 26.48% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ac
  • Accretion Pharma. - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    7 Jul 2026, 5:50PM Accretion Pharmaceuticals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
  • Accretion Pharma. - Resignation of Director/KMP/SMP

    6 Jul 2026, 2:58PM Accretion Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Accretion Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    6 Jul 2026, 2:47PM Accretion Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Accretion Pharma. - Resignation

    2 Jul 2026, 3:47PM Accretion Pharmaceuticals Limited has informed the Exchange regarding Resignation of Ms Bandana Kumari as HR Manager of the company w.e.f. July 02, 2
  • Accretion Pharma. - Reply to Clarification- Financial results

    25 Jun 2026, 4:36PM The Exchange had sought clarification from Accretion Pharmaceuticals Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SE
  • Accretion Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Jun 2026, 3:54PM Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Key fundamentals

Evaluate the intrinsic value of Accretion Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23
Assets 67.0297 29.39 18.8298 12.3085
Liabilities 67.0297 29.39 18.8298 12.3085
Equity 11.116 8.17 4 3.8427
Gross Profit 14.9738 11.8808 7.4894 1.9913
Net Profit 9.6675 6.7935 3.8753 0.1039
Cash From Operating Activities -14.5342 5.7499 -3.8569 0.3212
NPM(%) 10.78 11.84 11.51 0.35
Revenue 89.6272 57.3762 33.6652 29.3843
Expenses 74.6534 45.4954 26.1758 27.393
ROE(%) 17.67 12.41 7.08 0.18

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Accretion Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 831.10 -0.30 21.02 0.00 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 112.65 -2.13 1609.29 0.00 0.39 0.00
Vaishali Pharma Ltd 8.88 1.02 27.75 0.00 15.42 0.00
Astec Lifesciences Ltd 725.55 -0.16 0.00 0.00 -363.14 0.00

Company Info

In the year 2012, our Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of "Accretion Pharmaceuticals" was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Accretion Pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012. Our manufacturing facility which is currently located at 28 & 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat 382213, commenced its manufacturing operations in year 2014. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Accretion Pharmaceuticals Limited" and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.The Corporate Identification Number of our Company is U21004GJ2023PLC146545.Major Events:2012- Formed as a Partnership Firm in the name and style of "M/s Accretion pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012.2023-Incorporation of our Company "Accretion Pharmaceuticals Limited" as a Public Limited Company from conversion of "M/s Accretion Pharmaceuticals" a Partnership firm vide partner's resolution dated October 16, 2023.

In the year 2012, our Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of "Accretion Pharmaceuticals" was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Accretion Pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012. Our manufacturing facility which is currently located at 28 & 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat 382213, commenced its manufacturing operations in year 2014. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Accretion Pharmaceuticals Limited" and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.The Corporate Identification Number of our Company is U21004GJ2023PLC146545.Major Events:2012- Formed as a Partnership Firm in the name and style of "M/s Accretion pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012.2023-Incorporation of our Company "Accretion Pharmaceuticals Limited" as a Public Limited Company from conversion of "M/s Accretion Pharmaceuticals" a Partnership firm vide partner's resolution dated October 16, 2023.

Parent Organisation

Accretion Pharmaceuticals Ltd.

Founded

18/12/2012

Managing Director

Mr.Vivek Ashok Kumar Patel

NSE Symbol

ACCPLST

FAQ